LINC00342 promotes thyroid carcinoma progression by targeting miR-384/CHMP5 pathway
- Type
- Retraction
- Notice date
- 11/2/2020 0:00
- Journal
- Pathology: Research and Practice
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.prp.2020.153272
- Original paper DOI
- 10.1016/j.prp.2020.153272